Literature DB >> 11827630

Recent clinical trials in valvular heart diseases.

Maurice Enriquez-Sarano1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11827630     DOI: 10.1007/s11886-002-0017-5

Source DB:  PubMed          Journal:  Curr Cardiol Rep        ISSN: 1523-3782            Impact factor:   2.931


× No keyword cloud information.
  12 in total

1.  Outcomes 15 years after valve replacement with a mechanical versus a bioprosthetic valve: final report of the Veterans Affairs randomized trial.

Authors:  K Hammermeister; G K Sethi; W G Henderson; F L Grover; C Oprian; S H Rahimtoola
Journal:  J Am Coll Cardiol       Date:  2000-10       Impact factor: 24.094

2.  Prosthetic valve type for patients undergoing aortic valve replacement: a decision analysis.

Authors:  N J Birkmeyer; J D Birkmeyer; A N Tosteson; G L Grunkemeier; C A Marrin; G T O'Connor
Journal:  Ann Thorac Surg       Date:  2000-12       Impact factor: 4.330

3.  Self-managed anticoagulation: results from a two-year prospective randomized trial with heart valve patients.

Authors:  P Sidhu; H O O'Kane
Journal:  Ann Thorac Surg       Date:  2001-11       Impact factor: 4.330

4.  Beneficial effects of nicorandil versus enalapril in chronic rheumatic severe mitral regurgitation: six months follow up echocardiographic study.

Authors:  D K Gupta; A Kapoor; N Garg; S Tewari; N Sinha
Journal:  J Heart Valve Dis       Date:  2001-03

5.  An assessment of heart-valve abnormalities in obese patients taking dexfenfluramine, sustained-release dexfenfluramine, or placebo. Sustained-Release Dexfenfluramine Study Group.

Authors:  N J Weissman; J F Tighe; J S Gottdiener; J T Gwynne
Journal:  N Engl J Med       Date:  1998-09-10       Impact factor: 91.245

6.  Risks and benefits of adding anti-platelet therapy to warfarin among patients with prosthetic heart valves: a meta-analysis.

Authors:  D Massel; S H Little
Journal:  J Am Coll Cardiol       Date:  2001-02       Impact factor: 24.094

7.  Comparison of a daily fixed 2.5-mg warfarin dose with a 5-mg, international normalized ratio adjusted, warfarin dose initially following heart valve replacement.

Authors:  W Ageno; A G Turpie; L Steidl; F Ambrosini; R Cattaneo; R L Codari; B Nardo; A Venco
Journal:  Am J Cardiol       Date:  2001-07-01       Impact factor: 2.778

8.  Natural history of valvular regurgitation 1 year after discontinuation of dexfenfluramine therapy. A randomized, double-blind, placebo-controlled trial.

Authors:  N J Weissman; J A Panza; J F Tighe; J T Gwynne
Journal:  Ann Intern Med       Date:  2001-02-20       Impact factor: 25.391

9.  Echocardiographic examination of women previously treated with fenfluramine: long-term follow-up of a randomized, double-blind, placebo-controlled trial.

Authors:  R Davidoff; A McTiernan; G Constantine; K D Davis; G J Balady; L A Mendes; R E Rudolph; D J Bowen
Journal:  Arch Intern Med       Date:  2001-06-11

10.  Prospectively randomized comparison of different mechanical aortic valves.

Authors:  R Autschbach; T Walther; V Falk; M Kostelka; A Rösler; G Langebartels; M Krüger; A Diegeler; F W Mohr
Journal:  Circulation       Date:  2000-11-07       Impact factor: 29.690

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.